{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:00:47Z","timestamp":1786978847042,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":76,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031297496","type":"print"},{"value":"9783031297502","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-29750-2_2","type":"book-chapter","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T05:02:51Z","timestamp":1689051771000},"page":"5-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Presentation and Prognosis"],"prefix":"10.1007","author":[{"given":"Christopher P.","family":"Millward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumirat","family":"Keshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman I.","family":"Islim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"2_CR3","doi-asserted-by":"crossref","unstructured":"Buerki, R.A., et al., An overview of meningiomas. Future oncology (London, England), 2018. 14(21): p. 2161\u20132177.","DOI":"10.2217\/fon-2018-0006"},{"key":"2_CR4","doi-asserted-by":"crossref","unstructured":"Beaumont, A. and I.R. Whittle, The Pathogenesis of Tumour Associated Epilepsy. Acta Neurochirurgica, 2000. 142(1): p. 1\u201315.","DOI":"10.1007\/s007010050001"},{"key":"2_CR5","doi-asserted-by":"crossref","unstructured":"Baumgarten, P., et al., Focused review on seizures caused by meningiomas. Epilepsy & Behavior, 2018. 88: p. 146\u2013151.","DOI":"10.1016\/j.yebeh.2018.09.002"},{"key":"2_CR6","doi-asserted-by":"crossref","unstructured":"Tanti, M.J., A.G. Marson, and M.D. Jenkinson, Epilepsy and adverse quality of life in surgically resected meningioma. Acta Neurologica Scandinavica, 2017. 136(3): p. 246\u2013253.","DOI":"10.1111\/ane.12711"},{"key":"2_CR7","doi-asserted-by":"crossref","unstructured":"Lieu, A.-S. and S.-L. Howng, Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Research, 1999. 38(1): p. 45\u201352.","DOI":"10.1016\/S0920-1211(99)00066-2"},{"key":"2_CR8","doi-asserted-by":"crossref","unstructured":"Englot, D.J., et al., Seizures in supratentorial meningioma: a systematic review and meta-analysis. Journal of neurosurgery, 2016. 124(6): p. 1552\u20131561.","DOI":"10.3171\/2015.4.JNS142742"},{"key":"2_CR9","doi-asserted-by":"crossref","unstructured":"Alentorn, A., K. Hoang-Xuan, and T. Mikkelsen, Chapter 2 \u2013 Presenting signs and symptoms in brain tumors, in Handbook of Clinical Neurology, M.S. Berger and M. Weller, Editors. 2016, Elsevier. p. 19\u201326.","DOI":"10.1016\/B978-0-12-802997-8.00002-5"},{"key":"2_CR10","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., S. Kameyama, and R. Tanaka, Peritumoral Edema and Seizure in Patients with Cerebral Convexity and Parasagittal Meningiomas. Neurologia medico-chirurgica, 1996. 36(8): p. 568\u2013574.","DOI":"10.2176\/nmc.36.568"},{"key":"2_CR11","doi-asserted-by":"crossref","unstructured":"Xue, H., et al., Intracranial meningiomas and seizures: a review of the literature. Acta Neurochirurgica, 2015. 157(9): p. 1541\u20131548.","DOI":"10.1007\/s00701-015-2495-4"},{"key":"2_CR12","doi-asserted-by":"crossref","unstructured":"Islim, A.I., et al., The role of prophylactic antiepileptic drugs for seizure prophylaxis in meningioma surgery: A systematic review. Journal of Clinical Neuroscience, 2017. 43: p. 47\u201353.","DOI":"10.1016\/j.jocn.2017.05.020"},{"key":"2_CR13","doi-asserted-by":"crossref","unstructured":"Waagemans, M.L., et al., Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery, 2011. 69(1): p. 72\u201378; discussion 78\u201379.","DOI":"10.1227\/NEU.0b013e318212badb"},{"key":"2_CR14","doi-asserted-by":"crossref","unstructured":"Jenkinson, M.D., et al., Letter to the Editor. Establishing the role of prophylactic antiepileptic drugs in glioma and meningioma surgery. J Neurosurg, 2019: p. 1\u20133.","DOI":"10.3171\/2019.1.JNS19134"},{"issue":"6","key":"2_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/fampra\/cmv075","volume":"32","author":"M Schmidt-Hansen","year":"2015","unstructured":"Schmidt-Hansen, M., S. Berendse, and W. Hamilton, Symptomatic diagnosis of cancer of the brain and central nervous system in primary care: a systematic review. Family practice, 2015. 32(6): p. 618\u2013623.","journal-title":"Family practice"},{"issue":"6","key":"2_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11916-014-0421-8","volume":"18","author":"K Kahn","year":"2014","unstructured":"Kahn, K. and A. Finkel, It IS a Tumor- Current Review of Headache and Brain Tumor. Current Pain and Headache Reports, 2014. 18(6): p. 421.","journal-title":"Current Pain and Headache Reports"},{"issue":"3","key":"2_CR17","doi-asserted-by":"publisher","first-page":"s143","DOI":"10.1007\/s10072-004-0274-8","volume":"25","author":"A Boiardi","year":"2004","unstructured":"Boiardi, A., et al., Headache in brain tumours: a symptom to reappraise critically. Neurological Sciences, 2004. 25(3): p. s143\u2013s147.","journal-title":"Neurological Sciences"},{"key":"2_CR18","doi-asserted-by":"crossref","unstructured":"Freeman, W.D.M., Management of Intracranial Pressure.[Review]. CONTINUUM: Lifelong Learning in Neurology., 2015. 21(5, Neurocritical Care): p. 1299\u20131323.","DOI":"10.1212\/CON.0000000000000235"},{"issue":"2","key":"2_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-016-2115-z","volume":"128","author":"I Meskal","year":"2016","unstructured":"Meskal, I., et al., Cognitive functioning in meningioma patients: a systematic review. Journal of neuro-oncology, 2016. 128(2): p. 195\u2013205.","journal-title":"Journal of neuro-oncology"},{"issue":"3","key":"2_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5498\/wjp.v5.i3.273","volume":"5","author":"S Madhusoodanan","year":"2015","unstructured":"Madhusoodanan, S., et al., Psychiatric aspects of brain tumors: A review. World journal of psychiatry, 2015. 5(3): p. 273\u2013285.","journal-title":"World journal of psychiatry"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajp.2019.03.029","volume":"42","author":"S Gyawali","year":"2019","unstructured":"Gyawali, S., P. Sharma, and A. Mahapatra, Meningioma and psychiatric symptoms: An individual patient data analysis. Asian Journal of Psychiatry, 2019. 42: p. 94\u2013103.","journal-title":"Asian Journal of Psychiatry"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.wneu.2017.12.012","volume":"111","author":"A Wu","year":"2018","unstructured":"Wu, A., et al., Presenting Symptoms and Prognostic Factors for Symptomatic Outcomes Following Resection of Meningioma. World Neurosurgery, 2018. 111: p. e149\u2013e159.","journal-title":"World Neurosurgery"},{"issue":"1","key":"2_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000456538","volume":"9","author":"K Kumar","year":"2017","unstructured":"Kumar, K., et al., Tumors Presenting as Multiple Cranial Nerve Palsies. Case reports in neurology, 2017. 9(1): p. 54\u201361.","journal-title":"Case reports in neurology"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1016\/j.wneu.2019.01.171","volume":"125","author":"M Schneider","year":"2019","unstructured":"Schneider, M., et al., Cranial Nerve Outcomes After Surgery for Frontal Skull Base Meningiomas: The Eternal Quest of the Maximum-Safe Resection with the Lowest Morbidity. World Neurosurgery, 2019. 125: p. e790\u2013e796.","journal-title":"World Neurosurgery"},{"issue":"2","key":"2_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-018-2866-9","volume":"139","author":"A Faramand","year":"2018","unstructured":"Faramand, A., et al., Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas. Journal of Neuro-Oncology, 2018. 139(2): p. 341\u2013348.","journal-title":"Journal of Neuro-Oncology"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clineuro.2016.11.021","volume":"152","author":"SY Wayhs","year":"2017","unstructured":"Wayhs, S.Y., et al., Petroclival meningiomas: Remaining controversies in light of minimally invasive approaches. Clinical Neurology and Neurosurgery, 2017. 152: p. 68\u201375.","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"9420","key":"2_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","volume":"363","author":"IR Whittle","year":"2004","unstructured":"Whittle, I.R., et al., Meningiomas. The Lancet, 2004. 363(9420): p. 1535\u20131543.","journal-title":"The Lancet"},{"issue":"4","key":"2_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","volume":"105","author":"S Yano","year":"2006","unstructured":"Yano, S. and J. Kuratsu, Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg, 2006. 105(4): p. 538\u201343.","journal-title":"J Neurosurg"},{"issue":"5","key":"2_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3171\/2010.3.JNS091966","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue, M.E., et al., Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg, 2010. 113(5): p. 1036\u201342.","journal-title":"J Neurosurg"},{"issue":"2","key":"2_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-019-03104-3","volume":"142","author":"AI Islim","year":"2019","unstructured":"Islim, A.I., et al., Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol, 2019. 142(2): p. 211\u2013221.","journal-title":"J Neurooncol"},{"key":"2_CR31","doi-asserted-by":"crossref","unstructured":"Hashiba, T., et al., Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. 2009. 110(4): p. 675.","DOI":"10.3171\/2008.8.JNS08481"},{"issue":"2","key":"2_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11060-010-0319-1","volume":"102","author":"S Nakasu","year":"2011","unstructured":"Nakasu, S., et al., Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol, 2011. 102(2): p. 303\u201310.","journal-title":"J Neurooncol"},{"key":"2_CR33","doi-asserted-by":"publisher","unstructured":"Koncz, R., et al. Incidental findings on cerebral MRI in twins: the Older Australian Twins Study. Brain imaging and behavior, 2017. 1\u201310 DOI: https:\/\/doi.org\/10.1007\/s11682-017-9747-2.","DOI":"10.1007\/s11682-017-9747-2"},{"issue":"11","key":"2_CR34","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00701-019-04056-3","volume":"161","author":"F Brugada-Bellsola","year":"2019","unstructured":"Brugada-Bellsola, F., et al., Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score. Acta Neurochir (Wien), 2019. 161(11): p. 2233\u20132240.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"2_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/neuonc\/noz160","volume":"22","author":"AI Islim","year":"2019","unstructured":"Islim, A.I., et al., A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro-Oncology, 2019. 22(2): p. 278\u2013289.","journal-title":"Neuro-Oncology"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.wneu.2017.08.060","volume":"107","author":"EJ Lee","year":"2017","unstructured":"Lee, E.J., et al., \"Wait-and-See\" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure. World Neurosurg, 2017. 107: p. 604\u2013611.","journal-title":"World Neurosurg"},{"issue":"6","key":"2_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D.N., et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol, 2016. 131(6): p. 803\u201320.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2_CR38","first-page":"453","volume":"19","author":"MD Jenkinson","year":"2017","unstructured":"Jenkinson, M.D., et al., Atypical meningioma-is it time to standardize surgical sampling techniques? Neuro Oncol, 2017. 19(3): p. 453\u2013454.","journal-title":"Neuro Oncol"},{"issue":"5","key":"2_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/neuonc\/nov047","volume":"17","author":"A Olar","year":"2015","unstructured":"Olar, A., Phosphohistone H3: implications for clinical practice and risk assessment in meningioma. Neuro Oncol, 2015. 17(5): p. 631\u20133.","journal-title":"Neuro Oncol"},{"issue":"4","key":"2_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun, S.Q., et al., Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery, 2014. 75(4): p. 356\u201363.","journal-title":"Neurosurgery"},{"issue":"3","key":"2_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bpa.12174","volume":"25","author":"A Olar","year":"2015","unstructured":"Olar, A., et al., Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol, 2015. 25(3): p. 266\u201375.","journal-title":"Brain Pathol"},{"issue":"1","key":"2_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson, D., THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENT. J Neurol Neurosurg Psychiatry, 1957. 20(1): p. 22\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra, K.S., et al., Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys, 1997. 39(2): p. 427\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya, S., et al., Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg, 2012. 117(1): p. 121\u20138.","journal-title":"J Neurosurg"},{"issue":"6","key":"2_CR45","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3171\/2012.9.JNS12294","volume":"117","author":"H Bernt Filip","year":"2012","unstructured":"Bernt Filip, H., et al., Surgery for convexity meningioma: Simpson Grade I resection as the goal. Journal of Neurosurgery JNS, 2012. 117(6): p. 999\u20131006.","journal-title":"Journal of Neurosurgery JNS"},{"issue":"3","key":"2_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11060-010-0375-6","volume":"99","author":"MA Vogelbaum","year":"2010","unstructured":"Vogelbaum, M.A., et al., Opportunities for clinical research in meningioma. J Neurooncol, 2010. 99(3): p. 417\u201322.","journal-title":"J Neurooncol"},{"issue":"3","key":"2_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3171\/2015.9.JNS15754","volume":"125","author":"K Gousias","year":"2016","unstructured":"Gousias, K., J. Schramm, and M. Simon, The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg, 2016. 125(3): p. 551\u201360.","journal-title":"J Neurosurg"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.clineuro.2016.01.006","volume":"141","author":"MJ Gallagher","year":"2016","unstructured":"Gallagher, M.J., et al., WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant? Clin Neurol Neurosurg, 2016. 141: p. 117\u201321.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3171\/2016.1.JNS151842","volume":"126","author":"A Nanda","year":"2017","unstructured":"Nanda, A., et al., Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. J Neurosurg, 2017. 126(1): p. 201\u2013211.","journal-title":"J Neurosurg"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jocn.2016.03.014","volume":"31","author":"I Paldor","year":"2016","unstructured":"Paldor, I., et al., Review of controversies in management of non-benign meningioma. J Clin Neurosci, 2016. 31: p. 37\u201346.","journal-title":"J Clin Neurosci"},{"issue":"9","key":"2_CR51","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner, R., et al., EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol, 2016. 17(9): p. e383\u201391.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2_CR52","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3171\/2010.3.JNS091971","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue, M.E., et al., The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg, 2010. 113(5): p. 1029\u201335.","journal-title":"J Neurosurg"},{"issue":"1","key":"2_CR53","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1038\/s41598-019-42451-z","volume":"9","author":"JM Lemee","year":"2019","unstructured":"Lemee, J.M., et al., Extent of Resection in Meningioma: Predictive Factors and Clinical Implications. Sci Rep, 2019. 9(1): p. 5944.","journal-title":"Sci Rep"},{"issue":"1","key":"2_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10143-018-0976-7","volume":"42","author":"TR Meling","year":"2019","unstructured":"Meling, T.R., et al., Meningiomas: skull base versus non-skull base. Neurosurg Rev, 2019. 42(1): p. 163\u2013173.","journal-title":"Neurosurg Rev"},{"key":"2_CR55","doi-asserted-by":"crossref","unstructured":"Kressner, M., et al., Prognostic factors of microsurgical treatment of intracranial meningiomas \u2013 A multivariate analysis. PLoS One, 2018. 13(10): p. e0202520.","DOI":"10.1371\/journal.pone.0202520"},{"issue":"4","key":"2_CR56","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3171\/jns.2006.105.4.514","volume":"105","author":"MP Sindou","year":"2006","unstructured":"Sindou, M.P. and J.E. Alvernia, Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses. J Neurosurg, 2006. 105(4): p. 514\u201325.","journal-title":"J Neurosurg"},{"issue":"1","key":"2_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.wneu.2013.07.119","volume":"81","author":"M Sindou","year":"2014","unstructured":"Sindou, M., Meningiomas involving major dural sinuses: should we attempt at radical removal and venous repair? World Neurosurg, 2014. 81(1): p. 46\u20137.","journal-title":"World Neurosurg"},{"key":"2_CR58","doi-asserted-by":"crossref","unstructured":"Giordan, E., T.J. Sorenson, and G. Lanzino, Optimal surgical strategy for meningiomas involving the superior sagittal sinus: a systematic review. Neurosurg Rev, 2018.","DOI":"10.1007\/s10143-018-1026-1"},{"issue":"5110","key":"2_CR59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/216084a0","volume":"216","author":"KD Zang","year":"1967","unstructured":"Zang, K.D. and H. Singer, Chromosomal consitution of meningiomas. Nature, 1967. 216(5110): p. 84\u20135.","journal-title":"Nature"},{"issue":"15","key":"2_CR60","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1073\/pnas.84.15.5419","volume":"84","author":"BR Seizinger","year":"1987","unstructured":"Seizinger, B.R., et al., Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A, 1987. 84(15): p. 5419\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"MH Ruttledge","year":"1994","unstructured":"Ruttledge, M.H., et al., Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet, 1994. 6(2): p. 180\u20134.","journal-title":"Nat Genet"},{"issue":"4","key":"2_CR62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","volume":"20","author":"Y Lee","year":"2010","unstructured":"Lee, Y., et al., Genomic landscape of meningiomas. Brain Pathol, 2010. 20(4): p. 751\u201362.","journal-title":"Brain Pathol"},{"issue":"Suppl 1","key":"2_CR63","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.21037\/cco.2017.06.10","volume":"6","author":"WL Bi","year":"2017","unstructured":"Bi, W.L. and I.F. Dunn, Current and emerging principles in surgery for meningioma. Chin Clin Oncol, 2017. 6(Suppl 1): p. S7.","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"2_CR64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos, P.K., et al., Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet, 2013. 45(3): p. 285\u20139.","journal-title":"Nat Genet"},{"issue":"6123","key":"2_CR65","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark, V.E., et al., Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science, 2013. 339(6123): p. 1077\u201380.","journal-title":"Science"},{"issue":"3","key":"2_CR66","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss, D.E., et al., Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol, 2013. 125(3): p. 351\u20138.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"2_CR67","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark, V.E., et al., Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet, 2016. 48(10): p. 1253\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"2_CR68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","volume":"33","author":"S Yuzawa","year":"2016","unstructured":"Yuzawa, S., H. Nishihara, and S. Tanaka, Genetic landscape of meningioma. Brain Tumor Pathol, 2016. 33(4): p. 237\u2013247.","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"2_CR69","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi, M., et al., Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol, 2016. 18(5): p. 649\u201355.","journal-title":"Neuro Oncol"},{"issue":"3","key":"2_CR70","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"102","author":"S Kang","year":"2005","unstructured":"Kang, S., A.G. Bader, and P.K. Vogt, Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A, 2005. 102(3): p. 802\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2_CR71","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","volume":"91","author":"C Mirian","year":"2020","unstructured":"Mirian, C., et al., Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry, 2020. 91(4): p. 378.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"13","key":"2_CR73","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan, H.N., et al., Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Rep, 2018. 22(13): p. 3672\u20133683.","journal-title":"Cell Rep"},{"issue":"2","key":"2_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nan.12571","volume":"46","author":"H Kim","year":"2020","unstructured":"Kim, H., et al., Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression. Neuropathology and Applied Neurobiology, 2020. 46(2): p. 125\u2013141.","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"43","key":"2_CR75","doi-asserted-by":"publisher","first-page":"21715","DOI":"10.1073\/pnas.1912858116","volume":"116","author":"AJ Patel","year":"2019","unstructured":"Patel, A.J., et al., Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proceedings of the National Academy of Sciences, 2019. 116(43): p. 21715.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"2_CR76","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm, F., et al., DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol, 2017. 18(5): p. 682\u2013694.","journal-title":"Lancet Oncol"},{"issue":"7","key":"2_CR77","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri, F., et al., DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol, 2019. 21(7): p. 901\u2013910.","journal-title":"Neuro Oncol"},{"issue":"3","key":"2_CR78","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar, A., et al., Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol, 2017. 133(3): p. 431\u2013444.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2_CR79","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00701-019-04102-0","volume":"161","author":"MD Jenkinson","year":"2019","unstructured":"Jenkinson, M.D., \u2018Meningiomics\u2019-an integration of data on the patient, tumour, extent of resection and molecular pathology to optimise the management and follow-up for meningiomas. Acta Neurochir (Wien), 2019. 161(12): p. 2551\u20132552.","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Advances in Experimental Medicine and Biology","Biological and Clinical Landscape of Meningiomas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-29750-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T05:03:19Z","timestamp":1689051799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-29750-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031297496","9783031297502"],"references-count":76,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-29750-2_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"12 July 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}